Results 231 to 240 of about 27,460 (260)
Some of the next articles are maybe not open access.
Documenta Ophthalmologica, 1981
The occurrence of chronic progressive external ophthalmoplegia, pigmentary retinal dystrophy and cardiac disturbances associated with arachnodactily, sternal deformity, high arched palate and severe myopia is reported. A pedigree analysis of this Jewish-Iranian family strongly suggests that the condition is inherited as autosomal recessive trait.
V, Godel +4 more
openaire +2 more sources
The occurrence of chronic progressive external ophthalmoplegia, pigmentary retinal dystrophy and cardiac disturbances associated with arachnodactily, sternal deformity, high arched palate and severe myopia is reported. A pedigree analysis of this Jewish-Iranian family strongly suggests that the condition is inherited as autosomal recessive trait.
V, Godel +4 more
openaire +2 more sources
Ophthalmoplegia in Diabetes Mellitus
Annals of Internal Medicine, 1967Excerpt The occurrence of ocular nerve paralysis in a diabetic patient presents a dilemma from diagnostic, prognostic, and therapeutic points of view.
George P. Kozak, Eduardo Zorrilla
openaire +3 more sources
Pediatric Internuclear Ophthalmoplegia
Journal of Neuro-Ophthalmology, 2013Internuclear ophthalmoplegia (INO) is a rare eye movement disorder in the pediatric population.We performed a retrospective review at a university-based tertiary referral ophthalmology practice from 2004 to 2012 to identify pediatric patients with INO.Three patients with INO were identified.
Jennifer L. Rizzo +2 more
openaire +3 more sources
Amitriptyline‐induced ophthalmoplegia
Neurology, 1981Total external ophthalmoplegia, unresponsive to caloric stimulation, was observed in a gravid woman who had ingested approximately 1.0 to 1.5 gm of amitriptyline. The intravenous administration of 4.0 mg physostigmine salicylate (PS) produced a revival of consciousness and reflex activity but had no appreciable effect on ocular motility.
Robert Schnapper, Robert H. Spector
openaire +3 more sources
2015
Ophthalmoplegia is usually chronic, and therefore diplopia is not a feature. There is enough time for the brain to suppress one image. It is amazing how much of impairment of eye movement has to occur before the patient becomes concerned or considers it as abnormal.
openaire +1 more source
Ophthalmoplegia is usually chronic, and therefore diplopia is not a feature. There is enough time for the brain to suppress one image. It is amazing how much of impairment of eye movement has to occur before the patient becomes concerned or considers it as abnormal.
openaire +1 more source
Ophthalmoplegia in Powassan encephalitis
Neurology, 2003Powassan encephalitis, a rare arthropod-borne infection, is being increasingly recognized in New England, four cases having recently been reported.1 We describe an unusual ophthalmoplegia in one of these patients. In September 2000, a 53-year-old woman residing in Maine developed nausea, vomiting, diarrhea, dizziness, diplopia, and incoordination ...
T. Edward Collins, Simmons Lessell
openaire +3 more sources
Phenytoin‐induced ophthalmoplegia
Neurology, 1976Total external ophthalmoplegia was observed in five patients consequent to the oral or intravenous administration of phenytoin. Coincident with the ophthalmoplegia, the state of consciousness varied from drowsiness to coma and the blood levels of phenytoin ranged from 36 to 55 mug per milliliter.
Robert J. Schwartzman +2 more
openaire +3 more sources
The Internuclear Ophthalmoplegias [PDF]
, 1993 Internuclear ophthalmoplegia (INO), which is caused by an ipsilateral medial longitudinal fasciculus (MLF) lesion, is characterized by adduction paresis of lateral gaze, usually with spared convergence [1–4]. In the opposite eye, abduction nystagmus and hypermetric abduction saccades are the main clinical and electro-oculographic abnormalities [1, 5, 6]
openaire +1 more source
Reversible ophthalmoplegia in CPEO
Australian and New Zealand Journal of Ophthalmology, 1995Abstract Purpose: To present a case of improvement of ocular motility in a patient with chronic progressive external ophthalmoplegia (CPEO) with Coenzyme Q10. Methods: Coenzyme Q10 300 mg daily was given for three years with a three‐day trial period of 200 mg daily after one year. Ocular ductions were measured by synoptophore.
Iain S. Dunlop, Patricia Dunlop
openaire +2 more sources